The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype for updates and increased immunogenicity

导出原文传递

翻译打印收藏纠错

作者： Liu, Chengming ^[1] ; Zheng, Sufei ^[2] ; Jin, Runsen ^[3] ; Wang, Xinfeng ; Wang, Feng ; Zang, Ruochuan ; Xu, Haiyan ; Lu, Zhiliang ; Huang, Jianbing ; Lei, Yuanyuan ; Mao, Shuangshuang ; Wang, Yalong ; Feng, Xiaoli ; Sun, Nan ; Wang, Yan ; He, Jie

作者单位： Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Thorac Surg ^[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol ^[2] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Pathol,Natl ^[3]

关键词 KRAS PD-L1 TILs TMB NSCLC

发布时间 2020-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer letters

2020年470卷

95-105页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype for updates and increased immunogenicity

Cancer letters

相似文献

Cancer letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype for updates and increased immunogenicity

Cancer letters

相似文献

Cancer letters

相关期刊

检索历史清除